Perrigo Company plc Undistributed Earnings of Foreign Subsidiaries
Perrigo Company plc (PRGO) had Undistributed Earnings of Foreign Subsidiaries of $3.30 million as of 2024-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Notes › Income Taxes › Deferred Tax Liability Not Recognized, Undistributed Earnings of Foreign Subsidiaries
us-gaap:UndistributedEarningsOfForeignSubsidiaries · last filed 2025-02-28
- 2024-12-31: Undistributed Earnings of Foreign Subsidiaries $3.30M.
- 2023-12-31: Undistributed Earnings of Foreign Subsidiaries $3.50M.
- 2022-12-31: Undistributed Earnings of Foreign Subsidiaries $3.30M.
| Period end | Undistributed Earnings of Foreign Subsidiaries |
|---|---|
| 2024-12-31 | $3.30M 10-K · filed 2025-02-28 |
| 2023-12-31 | $3.50M 10-K · filed 2024-02-27 |
| 2022-12-31 | $3.30M 10-K · filed 2023-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |